Elanix Biotechnologies AG getting confirmation of Outperform Recommendation by goetzpartners securities
Outperform statement following webcast presentations to investors on 7 August, 2018 Statement is based on commercial roll-out plans presented by Elanix Management Share price target indicated by goetzpartners remains at EUR 6.40 Elanix Biotechnologies AG ("Elanix") has announced today that Mehr